NASDAQ:IRMD - Iradimed Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $22.30 -0.35 (-1.55 %) (As of 07/16/2018 04:00 PM ET)Previous Close$22.65Today's Range$21.61 - $22.7552-Week Range$8.30 - $23.58Volume34,604 shsAverage Volume24,079 shsMarket Capitalization$241.36 millionP/E Ratio275.63Dividend YieldN/ABeta1.39 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email IRadimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets under the MRidium name; and MRI compatible patient vital signs monitoring system under the IRadimed name. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its MRI compatible products through direct sales force and independent distributors. IRadimed Corporation was incorporated in 1992 and is headquartered in Winter Springs, Florida. Receive IRMD News and Ratings via Email Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolNASDAQ:IRMD CUSIPN/A Webwww.iradimed.com Phone407-677-8022 Debt Debt-to-Equity RatioN/A Current Ratio9.19 Quick Ratio8.10 Price-To-Earnings Trailing P/E Ratio275.63 Forward P/E Ratio69.69 P/E GrowthN/A Sales & Book Value Annual Sales$23.08 million Price / Sales10.30 Cash Flow$0.2121 per share Price / Cash105.13 Book Value$3.12 per share Price / Book7.15 Profitability EPS (Most Recent Fiscal Year)$0.08 Net Income$490,000.00 Net Margins6.29% Return on Equity6.27% Return on Assets5.32% Miscellaneous Employees83 Outstanding Shares10,660,000Market Cap$241.36 Iradimed (NASDAQ:IRMD) Frequently Asked Questions What is Iradimed's stock symbol? Iradimed trades on the NASDAQ under the ticker symbol "IRMD." How will Iradimed's stock buyback program work? Iradimed announced that its board has initiated a stock repurchase program on Sunday, June 4th 2017, which authorizes the company to repurchase $8,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued. How were Iradimed's earnings last quarter? Iradimed Corp (NASDAQ:IRMD) announced its quarterly earnings data on Monday, April, 30th. The medical equipment provider reported $0.10 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.06 by $0.04. The medical equipment provider had revenue of $7.11 million for the quarter, compared to analysts' expectations of $6.83 million. Iradimed had a return on equity of 6.27% and a net margin of 6.29%. View Iradimed's Earnings History. When is Iradimed's next earnings date? Iradimed is scheduled to release their next quarterly earnings announcement on Friday, July, 27th 2018. View Earnings Estimates for Iradimed. What price target have analysts set for IRMD? 2 analysts have issued 1-year price objectives for Iradimed's shares. Their predictions range from $16.00 to $19.00. On average, they anticipate Iradimed's share price to reach $17.50 in the next year. This suggests that the stock has a possible downside of 21.5%. View Analyst Ratings for Iradimed. What is the consensus analysts' recommendation for Iradimed? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Iradimed in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of Iradimed's key competitors? Some companies that are related to Iradimed include K2M Group (KTWO), Tactile Systems Technology (TCMD), Cerus (CERS), SurModics (SRDX), AngioDynamics (ANGO), LeMaitre Vascular (LMAT), Anika Therapeutics (ANIK), Endologix (ELGX), Antares Pharma (ATRS), Neuronetics (STIM), GenMark Diagnostics (GNMK), Inovio Pharmaceuticals (INO), Orthopediatrics (KIDS), Utah Medical Products (UTMD) and MiMedx Group (MDXG). Who are Iradimed's key executives? Iradimed's management team includes the folowing people: Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 65)Mr. Christopher K. Scott, CFO & Sec. (Age 48)Mr. John McCreery, Chief Operating Officer (Age 63)Mr. Brent Johnson, Exec. VP of Worldwide Sales & Marketing (Age 59)Mr. Louis Waldman, Controller (Age 63) Has Iradimed been receiving favorable news coverage? Media headlines about IRMD stock have trended somewhat negative recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Iradimed earned a daily sentiment score of 0.00 on Accern's scale. They also assigned news articles about the medical equipment provider an impact score of 44.27 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term. How do I buy shares of Iradimed? Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Iradimed's stock price today? One share of IRMD stock can currently be purchased for approximately $22.30. How big of a company is Iradimed? Iradimed has a market capitalization of $241.36 million and generates $23.08 million in revenue each year. The medical equipment provider earns $490,000.00 in net income (profit) each year or $0.08 on an earnings per share basis. Iradimed employs 83 workers across the globe. How can I contact Iradimed? Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected] MarketBeat Community Rating for Iradimed (NASDAQ IRMD)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 136 (Vote Outperform)Underperform Votes: 129 (Vote Underperform)Total Votes: 265MarketBeat's community ratings are surveys of what our community members think about Iradimed and other stocks. Vote "Outperform" if you believe IRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRMD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: What is the Book Value of a Share?